Buradasınız

Anasayfa » Content

BODY FRIENDLY, SAFE AND EFFECTIVE REGIMEN OF MgSO4 FOR ECLAMPSIA

BODY FRIENDLY, SAFE AND EFFECTIVE REGIMEN OF MgSO4 FOR ECLAMPSIA

Journal Name:

  • International Journal of Medical Research & Health Sciences

Publication Year:

  • 2013

Key Words:

Author Name
Abstract (2. Language): 
Pre-eclampsia and eclampsia are major health problems in developing countries. MgSO4 is the standard drug in the control of convulsions in eclampsia. Our study carried out at PDVVPF’s hospital is based on the low dose regimen than Pritchard, which is suitable for Indian women who are of smaller built than women in western world. This prospective study included 50 eclampsia patients receiving low dose MgSO4 therapy. The loading dose of MgSO4 was 9gm. Following this 2.5 gm was given intramuscularly every 6 hourly for 24 hours after administration of the loading dose. Patients were monitored hourly by observing their respiratory rate, knee jerk and urine output. Out of 50, two patients required Pritchard regimen, rest completely recovered from eclampsia. The maternal and perinatal morbidity and mortality were comparable to those of the standard Pritchard regime. The study did not find a single case of magnesium related toxicity with low dose MgSO4 regime. Low dose magnesium sulphate regime was found to be safe and effective in eclampsia.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon arastirmax-body-friendly-safe-and-effective-regimen-mgso4-eclampsia.pdf
  • 1
83-86
  • Turkish

REFERENCES

References: 

1. Duley L. Maternal mortality associated with
hypertensive disorders of pregnancy in Africa,
Asia, Latin America and the Caribbean. Br J
ObstetGynaecol. 1992;99:547-53.
2. The Eclampsia Trial Collaborative Group.
Which anticonvulsant for women with
eclampsia? Evidence from Collaborative
Eclampsia Trial.Lancet. 1995; 345:1445-63
3. Jack A. Pritchard, Cunningham G et al. The
Parkland Memorial Hospital Protocol for
treatment of eclampsia: Evaluation of 245
cases. Am. J. ObstetGynacol. 1984;148:951-
63.
4. Phaupradit Winit, Saropala N et al, Serum
level of Magnesium attained in Magnesium
Sulphate therapy for severe preeclampsia.
Asia Oceania J. Obstet& Gyn. 1993; 194:387-
89
5. Ekele BA, Bello SO, Adamu AN. Clusters of
eclampsia in a Nigerian teaching hospital. Int
J Gynecol Obstet. 2007;96:62–66.
6. Bugalho A, Bacci A, Bergstrom S. Risk
factors in Mozambican women with
Eclampsia: A case-referent study. Afr J Repro
Health. 2001;5:30–35.
7. Rashida Begum. Anowara Begum, Richard
Johnson et al. A low dose (Dhaka) magnesium
sulphate regime for eclampsia. Acta
Obstetricaet Gynecologica Scandinavica 2001;
80(1):998.
8. Begum MR, Begum A, Quadir E. Loading
dose versus standard regime of magnesium
sulphate in the management of eclampsia: a
randomized trial. J ObstetGynaecol Res.
2002;28:154–59.
9. Sardesai Suman, MairaShivanjali, PatilAjit et
al. Low dose magnesium sulphate therapy for
eclampsia and imminent eclampsia- Regime
tailored for Indian women. J. Obstet Gynecol
India 2003; 53-6: 546-550

Thank you for copying data from http://www.arastirmax.com